Degradation of cross-linked and non-cross-linked arabinoxylans by the intestinal microbiota in children

被引:137
作者
Hopkins, MJ
Englyst, HN
Macfarlane, S
Furrie, E
Macfarlane, GT
McBain, AJ
机构
[1] Univ Dundee, MRC, Microbiol & Gut Biol Grp, Dundee DD1 4HN, Scotland
[2] Englyst Carbohydrates Res & Serv Ltd, Southampton, Hants, England
[3] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PL, Lancs, England
关键词
D O I
10.1128/AEM.69.11.6354-6360.2003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In humans, nonstarch polysaccharides (NSP), such as arabinoxylans (AX), are not digested in the upper gut and provide fermentable carbon sources for bacteria growing in the large bowel. Despite the ubiquity of AX in nature, the microbiologic and physiologic consequences of AX digestion in the gut are poorly understood. In this study, we investigated the breakdown of ferulic acid-cross-linked AX (AXF) and non-cross-linked AX in children's intestinal microbiotas, using starch as a readily fermentable polysaccharide for comparative purposes. The experiments were performed using pH-controlled fermentation vessels under anaerobic conditions. The results demonstrated that there was variation in the metabolism of these polysaccharides by colonic microbiotas. AX was always degraded more slowly than starch, while ferulic acid cross-linking reduced the rate of AX fermentation, as shown by fermentation product measurements. Starch digestion was associated with significant acetate and butyrate production, whereas AX breakdown resulted in increased propionate formation. In general, the presence of fermentable carbohydrate significantly increased the total anaerobe counts and eubacterial rRNA concentrations (P < 0.01), while non-cross-linked AX digestion was principally associated with increased viable counts of Bacteroides fragilis group organisms, which was supported by increases in Bacteroides-Porphyromonas-Prevotella group rRNA (P < 0.01). Starch was considerably more bifidogenic than AX in these fermentations. In conclusion, in this study we found that the effects of AX and AXF on the microbial ecology and metabolism of intestinal microbiotas are similar in children and adults.
引用
收藏
页码:6354 / 6360
页数:7
相关论文
共 54 条
[21]   QUANTITATIVE FLUORESCENCE IN-SITU HYBRIDIZATION OF BIFIDOBACTERIUM SPP WITH GENUS-SPECIFIC 16S RIBOSOMAL-RNA-TARGETED PROBES AND ITS APPLICATION IN FECAL SAMPLES [J].
LANGENDIJK, PS ;
SCHUT, F ;
JANSEN, GJ ;
RAANGS, GC ;
KAMPHUIS, GR ;
WILKINSON, MHF ;
WELLING, GW .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1995, 61 (08) :3069-3075
[22]  
MACFARLANE GT, 1991, APPL ENVIRON MICROB, V57, P1
[23]  
MACFARLANE GT, 1991, FEMS MICROBIOL LETT, V77, P289, DOI 10.1111/j.1574-6968.1991.tb04363.x
[24]   EFFECT OF DIFFERENT CARBOHYDRATES ON GROWTH, POLYSACCHARIDASE AND GLYCOSIDASE PRODUCTION BY BACTERIODES-OVATUS, IN BATCH AND CONTINUOUS CULTURE [J].
MACFARLANE, GT ;
HAY, S ;
MACFARLANE, S ;
GIBSON, GR .
JOURNAL OF APPLIED BACTERIOLOGY, 1990, 68 (02) :179-187
[25]   STARCH UTILIZATION BY THE HUMAN LARGE INTESTINAL MICROFLORA [J].
MACFARLANE, GT ;
ENGLYST, HN .
JOURNAL OF APPLIED BACTERIOLOGY, 1986, 60 (03) :195-201
[26]  
MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x
[27]  
MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647
[28]   Polysaccharide degradation by human intestinal bacteria during growth under multi-substrate limiting conditions in a three-stage continuous culture system [J].
Macfarlane, S ;
Quigley, ME ;
Hopkins, MJ ;
Newton, DF ;
Macfarlane, GT .
FEMS MICROBIOLOGY ECOLOGY, 1998, 26 (03) :231-243
[29]   Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites [J].
McBain, AJ ;
Macfarlane, GT .
JOURNAL OF MEDICAL MICROBIOLOGY, 1998, 47 (05) :407-416
[30]   Modulation of genotoxic enzyme activities by nondigestible oligosaccharide metabolism in in-vitro human gut bacterial ecosystems [J].
McBain, AJ ;
MacFarlane, GT .
JOURNAL OF MEDICAL MICROBIOLOGY, 2001, 50 (09) :833-842